Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma-Reference-Cited by-同舟云学术

Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma

Published:2020-09-22 Issue:9 Volume:15 Page:e0239386
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Loosen Sven H.,Wirtz Theresa H.,Roy Sanchari,Vucur Mihael,Castoldi Mirco,Schneider Anne T.,Koppe Christiane,Ulmer Tom F.,Roeth Anjali A.,Bednarsch Jan,Alizai Patrick H.,Paffenholz Pia,Demir Münevver,Trautwein Christian,Tacke Frank^ORCID,Neumann Ulf P.,Roderburg Christoph^ORCID,Luedde Tom

Funder

European Research Council

DRG

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;HB El-Serag;Gastroenterology,2007

2. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis;Y Ghouri;J Carcinog,2017

3. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial;J Bruix;Lancet Oncol,2015

4. Hester CA, Yopp AC (2019) Surgical Therapies in Hepatocellular Carcinoma.

5. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma;PR Galle;J Hepatol,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The challenges and potential in developing microRNA associated with regeneration as biomarkers to improve prognostication for liver failure syndromes and hepatocellular carcinoma;Expert Review of Molecular Diagnostics;2023-12-07

2. Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma;Frontiers in Oncology;2023-07-20

3. Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025;Zeitschrift für Gastroenterologie;2022-09

4. Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025;Zeitschrift für Gastroenterologie;2022-09

5. Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?;Frontiers in Oncology;2022-08-11